Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
873 | 2909 | 34.9 | 76% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
380 | 16446 | STREPTOCOCCUS PNEUMONIAE//COMMUNITY ACQUIRED PNEUMONIA//PNEUMOCOCCAL CONJUGATE VACCINE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | COMMUNITY ACQUIRED PNEUMONIA | Author keyword | 532 | 53% | 24% | 708 |
2 | PNEUMONIA SEVERITY INDEX | Author keyword | 50 | 74% | 1% | 37 |
3 | CURB 65 | Author keyword | 35 | 81% | 1% | 21 |
4 | HEALTHCARE ASSOCIATED PNEUMONIA | Author keyword | 32 | 60% | 1% | 35 |
5 | SEVERE COMMUNITY ACQUIRED PNEUMONIA | Author keyword | 24 | 68% | 1% | 21 |
6 | NURSING AND HEALTHCARE ASSOCIATED PNEUMONIA | Author keyword | 21 | 90% | 0% | 9 |
7 | THORAXZENTRUM RUHRGEBIET | Address | 20 | 59% | 1% | 23 |
8 | NURSING HOME ACQUIRED PNEUMONIA | Author keyword | 19 | 80% | 0% | 12 |
9 | KLINIKEN PNEUMOL INFEKTIOL | Address | 17 | 68% | 1% | 15 |
10 | CRB 65 | Author keyword | 14 | 100% | 0% | 7 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | REQUIRING HOSPITALIZATION | 138 | 60% | 5% | 152 |
2 | COMMUNITY ACQUIRED PNEUMONIA | 125 | 14% | 28% | 811 |
3 | BACTEREMIC PNEUMOCOCCAL PNEUMONIA | 116 | 64% | 4% | 113 |
4 | PNEUMOCOCCAL PNEUMONIA | 62 | 24% | 8% | 229 |
5 | CARE ASSOCIATED PNEUMONIA | 57 | 49% | 3% | 85 |
6 | HIGH DOSAGE AMOXICILLIN | 45 | 94% | 1% | 16 |
7 | ANTIMICROBIAL THERAPY | 42 | 17% | 8% | 235 |
8 | ORAL MOXIFLOXACIN | 41 | 63% | 1% | 42 |
9 | LOW RISK PATIENTS | 38 | 24% | 5% | 136 |
10 | SEVERITY CRITERIA | 38 | 93% | 0% | 14 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults | 2007 | 1649 | 293 | 54% |
Clinical and economic burden of community-acquired pneumonia among adults in Europe | 2012 | 127 | 91 | 87% |
Guidelines for the management of adults with community-acquired pneumonia - Diagnosis, assessment of severity, antimicrobial therapy, and prevention | 2001 | 1141 | 140 | 64% |
Healthcare-Associated Pneumonia Does Not Accurately Identify Potentially Resistant Pathogens: A Systematic Review and Meta-Analysis | 2014 | 23 | 42 | 86% |
Estimating the Burden of Pneumococcal Pneumonia among Adults: A Systematic Review and Meta-Analysis of Diagnostic Techniques | 2013 | 28 | 52 | 79% |
Community-Acquired Pneumonia | 2014 | 11 | 82 | 65% |
Prognosis and outcomes of patients with community-acquired pneumonia - A meta-analysis | 1996 | 706 | 94 | 55% |
Macrolide-Based Regimens and Mortality in Hospitalized Patients With Community-Acquired Pneumonia: A Systematic Review and Meta-analysis | 2012 | 34 | 34 | 71% |
Risk factors for community-acquired pneumonia in adults in Europe: a literature review | 2013 | 31 | 75 | 45% |
The aetiology and antibiotic management of community-acquired pneumonia in adults in Europe: a literature review | 2014 | 7 | 58 | 67% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | THORAXZENTRUM RUHRGEBIET | 20 | 59% | 0.8% | 23 |
2 | KLINIKEN PNEUMOL INFEKTIOL | 17 | 68% | 0.5% | 15 |
3 | CONSORCI HOSP GEN | 6 | 80% | 0.1% | 4 |
4 | ENFERMEDADES P | 5 | 22% | 0.7% | 19 |
5 | AO SAN GERARDO | 5 | 32% | 0.4% | 12 |
6 | DIRECC ATENC PRIMARIA CAMP TARRAGONA | 4 | 75% | 0.1% | 3 |
7 | IRCCS FDN CA GRANDA OSPED MAGGIORE | 4 | 50% | 0.2% | 6 |
8 | TAYSIDE P GRP | 4 | 36% | 0.3% | 8 |
9 | VERDICT PROGRAM | 3 | 57% | 0.1% | 4 |
10 | ENFERMEDADES PIRATORIAS | 3 | 100% | 0.1% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000112932 | ANTIGENURIA//ANTIGEN DETECTION TESTS//CAPSULAR POLYSACCHARIDE ANTIGENS |
2 | 0.0000100115 | LONG TERM CARE FACILITIES//EPIDEMIOL INFORMAT SYST MODELLING//MULTIDRUG RESISTANT GRAM NEGATIVE |
3 | 0.0000092762 | PRULIFLOXACIN//ACUTE EXACERBATIONS OF CHRONIC BRONCHITIS//ACUTE EXACERBATION OF CHRONIC BRONCHITIS |
4 | 0.0000078265 | IMAGE DIAG UNIT//CHILD LUNG HLTH//CHILDHOOD PNEUMONIA |
5 | 0.0000077359 | PENICILLIN RESISTANCE//PENICILLIN RESISTANT PNEUMOCOCCI//EENHEID ANTIBIOT ONDERZOEK |
6 | 0.0000075436 | PNEUMOCOCCAL POLYSACCHARIDE VACCINE//PNEUMOCOCCAL VACCINE//23 VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE |
7 | 0.0000073682 | GEMIFLOXACIN//GEMIFLOXACIN MESYLATE//GARENOXACIN |
8 | 0.0000072316 | TELITHROMYCIN//MACROLIDE RESISTANCE//CEFDITOREN |
9 | 0.0000064711 | MYCOPLASMA PNEUMONIAE//MYCOPLASMA PNEUMONIA//MACROLIDE RESISTANT |
10 | 0.0000058810 | PROCALCITONIN//PRESEPSIN//NEUTROPHIL CD64 |